Auteurs

Chris Thornham

Associé

Read More

Laurence Lieberman

Associé

Read More

Colin McCall

Associé

Read More
Auteurs

Chris Thornham

Associé

Read More

Laurence Lieberman

Associé

Read More

Colin McCall

Associé

Read More

31 octobre 2019 | 45:31

Arbitration: considerations for life science companies

In the second instalment of our Life Sciences Disputes webinar series, Arbitration: considerations for life science companies, we provide practical tips and advice, discuss key legislation and share case studies on how life sciences organisations can mitigate and manage their litigation risk.

Topics covered in the webinar include:

  • What subject matter can be arbitrated and how arbitration may arise?
  • Typical advantages/disadvantages of arbitration versus litigation.
  • Industry-specific points for parties in the life sciences considering arbitration.
  • Arbitration proceedings rules, tribunal composition, location and choice of law.
  • Decisions, remedies, enforcement and challenges
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Sciences de la vie et Santé

Termination, force majeure and frustration – international perspectives on the life sciences sector

17 avril 2020
QUICK READ

par plusieurs auteurs

Cliquer ici pour en savoir plus
Arbitrage international

Arbitration considerations for life science companies

29 septembre 2019

par plusieurs auteurs

Cliquer ici pour en savoir plus

Événements connexes